Chem-Space launches to provide largest global chemical database and search tool
![](/46/pdcnewsitem/03/93/29/clip_image001%20(4).jpg)
Chem-space.com online searchable marketplace features over 15 million compounds.
A group of chemical suppliers including Enamine, ChemBridge Corporation, UORSY and FCH Group, have announced launch of Chem-Space (www.chem-space.com), a global e-procurement marketplace solution for searching, purchasing and selling chemical building blocks. The Chem-Space database currently encompasses over 15 million unique molecular building blocks, and is the world’s largest chemicals library. The online catalogue offers an easy, fast search facility, enabling users to enter a broad range of search parameters such as substructure and various text identifiers.
Use of the Chem-Space database is free-of-charge for both suppliers and customers. There are no license fees for users to review and access the platform, and no commission charges for suppliers selling products. Chem-Space invites global chemistry suppliers, ranging from small to large organizations, to upload their catalogues to the site, to provide an efficient solution for buyers when sourcing building blocks.
The new platform is focused on speed of delivery, aiming to supply chemical molecules within a minimum of 5 days, to a maximum of 6 weeks. These delivery deadlines ensure that vendors list only realistic and feasible molecules. Customers can forward their product requests directly to suppliers via the site, to identify the best prices for building blocks on the market.
David Lonergan, Director of Business Development at Chem-Space, said: “We are launching Chem-Space to address the issue of reliability of building block offerings. We aim to support customers in accessing the chemicals they need, at the best price, with rapid delivery, directly from suppliers.”
Dr Sergey Altshteyn, President of ChemBridge, commented: “This initiative is a unique e-commerce platform, providing not only the world’s largest chemical building blocks product range, but also a user friendly interface, through which it is possible to efficiently procure products online. We encourage building block producers to join the free-of-charge platform to fully benefit from an optimal showcase.”
“We are delighted to support Chem-Space in developing the world’s most comprehensive database of medchem building blocks. The site offers the possibility to display our innovative molecules as soon as they appear in our own catalogue,” said Vladimir Ivanov, Chief Sales and Marketing Officer, Enamine.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance